FDA Inspection 1169368 — Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.
The FDA completed an inspection of Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A. on September 30, 2021 in Colleretto Giacosa. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 30, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Colleretto Giacosa (Italy)
Additional Details
Mutual Recognition Agreement (MRA)